---
title: ClinActis Pte Ltd vs Clarenta
slug_a: clinactis
slug_b: comac-medical
site: cro
review_signal_gate: closed
canonical_path: /compare/clinactis/comac-medical
generated_by: BioBM Editorial AI
---

# ClinActis Pte Ltd vs Clarenta

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

ClinActis Pte Ltd (clinactis) is listed for cro. Full-service CRO delivering clinical trial services across Asia Pacific, with 50+ years of cumulative experience managing Phase I–IV trials and expertise in oncology, cardiovascular, CNS, and infectious disease indications.

Services: 10. Modalities: 0. Indications: 5. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Clarenta (comac-medical) is listed for cro. Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.

Services: 8. Modalities: 0. Indications: 7. Locations: 10. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (10).

Review summary: Review summary withheld until site-level review gate opens.